Alto Neuroscience earnings were -$84.2M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ANRO earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$27.6M, up 5.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ANRO reported annual earnings of -$63.2M, with 2.9% growth. The next ANRO earnings date is Nov 11, 2026.
What were Alto Neuroscience's earnings last quarter?
On ANRO's earnings call on Aug 12, 2026, Alto Neuroscience (NYSE: ANRO) reported Q2 2026 earnings per share (EPS) of -$0.65, up 0% year over year. Total ANRO earnings for the quarter were -$27.64 million. In the same quarter last year, Alto Neuroscience's earnings per share (EPS) was -$0.65.
The next ANRO earnings date is Nov 11, 2026. Add ANRO to your watchlist to be reminded of Alto Neuroscience's next earnings date.
Is Alto Neuroscience profitable or losing money?
As of the last Alto Neuroscience earnings report, Alto Neuroscience is currently losing money. Alto Neuroscience's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$84.24 million, a 29.88% increase year over year.
What was ANRO's earnings growth in the past year?
As of Alto Neuroscience's earnings date in Aug 12, 2026, Alto Neuroscience's earnings has grown year over year. ANRO earnings in the past year totalled -$84.24 million.
What are Alto Neuroscience's earnings expectations?
The current EPS estimate for Alto Neuroscience's earnings report in Nov 11, 2026 is -$0.60.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.